179 related articles for article (PubMed ID: 17360344)
1. Synthesis and evaluation of transthyretin amyloidosis inhibitors containing carborane pharmacophores.
Julius RL; Farha OK; Chiang J; Perry LJ; Hawthorne MF
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):4808-13. PubMed ID: 17360344
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug, flufenamic acid.
Baures PW; Oza VB; Peterson SA; Kelly JW
Bioorg Med Chem; 1999 Jul; 7(7):1339-47. PubMed ID: 10465408
[TBL] [Abstract][Full Text] [Related]
3. Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis.
Tojo K; Sekijima Y; Kelly JW; Ikeda S
Neurosci Res; 2006 Dec; 56(4):441-9. PubMed ID: 17028027
[TBL] [Abstract][Full Text] [Related]
4. Amyloid disease prevention by transthyretin native state complexation with carborane derivatives lacking cyclooxygenase inhibition.
Julius RL; Hawthorne MF
Drug News Perspect; 2008 Jun; 21(5):258-66. PubMed ID: 18596990
[TBL] [Abstract][Full Text] [Related]
5. Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis.
Adamski-Werner SL; Palaninathan SK; Sacchettini JC; Kelly JW
J Med Chem; 2004 Jan; 47(2):355-74. PubMed ID: 14711308
[TBL] [Abstract][Full Text] [Related]
6. Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative.
Almeida MR; Macedo B; Cardoso I; Alves I; Valencia G; Arsequell G; Planas A; Saraiva MJ
Biochem J; 2004 Jul; 381(Pt 2):351-6. PubMed ID: 15080795
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the fibrillogenesis inhibition properties of two transthyretin ligands by halogenation.
Cotrina EY; Pinto M; Bosch L; Vilà M; Blasi D; Quintana J; Centeno NB; Arsequell G; Planas A; Valencia G
J Med Chem; 2013 Nov; 56(22):9110-21. PubMed ID: 24147937
[TBL] [Abstract][Full Text] [Related]
8. Drug competition for thyroxine binding to transthyretin (prealbumin): comparison with effects on thyroxine-binding globulin.
Munro SL; Lim CF; Hall JG; Barlow JW; Craik DJ; Topliss DJ; Stockigt JR
J Clin Endocrinol Metab; 1989 Jun; 68(6):1141-7. PubMed ID: 2498384
[TBL] [Abstract][Full Text] [Related]
9. Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity.
Useini L; Mojić M; Laube M; Lönnecke P; Mijatović S; Maksimović-Ivanić D; Pietzsch J; Hey-Hawkins E
ChemMedChem; 2023 Mar; 18(5):e202200583. PubMed ID: 36583943
[TBL] [Abstract][Full Text] [Related]
10. Discovering transthyretin amyloid fibril inhibitors by limited screening.
Baures PW; Peterson SA; Kelly JW
Bioorg Med Chem; 1998 Aug; 6(8):1389-401. PubMed ID: 9784876
[TBL] [Abstract][Full Text] [Related]
11. Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis.
Sekijima Y; Dendle MA; Kelly JW
Amyloid; 2006 Dec; 13(4):236-49. PubMed ID: 17107884
[TBL] [Abstract][Full Text] [Related]
12. Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors.
Mairal T; Nieto J; Pinto M; Almeida MR; Gales L; Ballesteros A; Barluenga J; Pérez JJ; Vázquez JT; Centeno NB; Saraiva MJ; Damas AM; Planas A; Arsequell G; Valencia G
PLoS One; 2009; 4(1):e4124. PubMed ID: 19125186
[TBL] [Abstract][Full Text] [Related]
13. Novel transthyretin amyloid fibril formation inhibitors: synthesis, biological evaluation, and X-ray structural analysis.
Palaninathan SK; Mohamedmohaideen NN; Orlandini E; Ortore G; Nencetti S; Lapucci A; Rossello A; Freundlich JS; Sacchettini JC
PLoS One; 2009 Jul; 4(7):e6290. PubMed ID: 19621084
[TBL] [Abstract][Full Text] [Related]
14. Rational design of potent human transthyretin amyloid disease inhibitors.
Klabunde T; Petrassi HM; Oza VB; Raman P; Kelly JW; Sacchettini JC
Nat Struct Biol; 2000 Apr; 7(4):312-21. PubMed ID: 10742177
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization.
Green NS; Palaninathan SK; Sacchettini JC; Kelly JW
J Am Chem Soc; 2003 Nov; 125(44):13404-14. PubMed ID: 14583036
[TBL] [Abstract][Full Text] [Related]
16. Carborane-Based Tebufelone Analogs and Their Biological Evaluation In Vitro.
Braun S; Paskaš S; Laube M; George S; Hofmann B; Lönnecke P; Steinhilber D; Pietzsch J; Mijatović S; Maksimović-Ivanić D; Hey-Hawkins E
ChemMedChem; 2023 Jul; 18(14):e202300206. PubMed ID: 37160667
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of monosubstituted functional derivatives of carboranes from 1-mercapto-ortho-carborane: 1-HOOC(CH(2))(n)S-1,2-C(2)B(10)H(11) and [7-HOOC(CH(2))(n)S-7,8-C(2)B(9)H(11)](-) (n = 1-4).
Stogniy MY; Sivaev IB; Petrovskii PV; Bregadze VI
Dalton Trans; 2010 Feb; 39(7):1817-22. PubMed ID: 20449427
[TBL] [Abstract][Full Text] [Related]
18. Cell based screening of inhibitors of transthyretin aggregation.
Reixach N; Adamski-Werner SL; Kelly JW; Koziol J; Buxbaum JN
Biochem Biophys Res Commun; 2006 Sep; 348(3):889-97. PubMed ID: 16904635
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, structure, and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors.
Oza VB; Smith C; Raman P; Koepf EK; Lashuel HA; Petrassi HM; Chiang KP; Powers ET; Sachettinni J; Kelly JW
J Med Chem; 2002 Jan; 45(2):321-32. PubMed ID: 11784137
[TBL] [Abstract][Full Text] [Related]
20. Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis.
Green NS; Foss TR; Kelly JW
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14545-50. PubMed ID: 16195386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
